YD

Yizhen Dong

Life Sciences & Healthcare

United States

Overview 

Yizhen Dong is an accomplished professional in the Life Sciences & Healthcare sector, currently serving as a Healthcare & Life Sciences Growth Equity leader at Koch Disruptive Technologies. With a strong background in venture capital and management consulting, Yizhen has excelled in roles such as Co-Founder at Nox Therapeutics and Partner at Global Founders Capital, demonstrating expertise in strategic planning and financial analysis.

Work Experience 

  • Healthcare & Life Sciences Growth Equity

    2022 - 2024

    Healthcare software and tech-enabled services Life sciences software, tools, services AI/ML in biotech and healthcare

Koch Disruptive Technologies is a venture capital firm that invests in technologies to improve businesses and create new opportunities.

  • Board Director

    2022 - 2024

    Led Series B and co-invested with Bessemer Venture Partners, Flare Capital, Takeda Ventures, CVS Ventures

Oshi Health is a digital health platform that provides personalized support and resources for people with digestive health conditions.

Raised $119,500,000.00 from Takeda Digital Ventures, Bessemer Venture Partners, CVS Health Ventures, Frist Cressey Ventures, Flare Capital Partners and Oak HC/FT.

  • Board Observer

    2022 - 2024

Artera develops multimodal artificial intelligence-based predictive and prognostic cancer tests to customize treatments for cancer patients.

Raised $110,000,000.00 from Trium, Andrew Tan, AIspace Ventures, Rajiv Khemani, Walden Catalyst, Wilson Sonsini Goodrich & Rosati, EDBI, Prosperity7 Ventures, Navin Chaddha and Coatue.

  • Board Observer

    2022 - 2024

    Led Series C and co-invested with Eclipse VC, Decheng Capital, and DFJ Growth

Cellares is a life sciences technology company that develops the Cell Shuttle to automate cell therapy manufacturing.

Raised $355,000,000.00 from 8VC, Koch Disruptive Technologies, Eclipse Ventures, DFJ Growth, Bristol-Myers Squibb, Decheng Capital and Willett Advisors LLC.

  • Co-Founder & Interim CEO

    2020 - 2024

    Co-founded startups in therapeutics and pharma services

  • Life Sciences & Healthcare Partner, VC & Growth Equity

    2020 - 2022

  • Principal, Life Sciences and Healthcare VC

    2016 - 2020

  • Board Observer

    2016 - 2020

Hinge Health is a digital clinic for joint, and muscle care, pelvic pain, bowel, and bladder control.

Raised $826,132,500.00 from Alkeon Capital and Whale Rock Capital Management.

  • Strategic Planning

    2013 - 2014

    Product launch Real world evidence Commercial strategies Market research, forecasting

Genentech specializes in genetic testing and personalized medicine.

  • Management Consultant

    2011 - 2014

    Real World Evidence (RWE) analytics Biotech M&A transactions Market Research

Articles About Yizhen

Relevant Websites